Protein kinase regulators
US11091477B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 14, 2017 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Aug 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds and pharmaceutically acceptable salts capable of modulating the activity of kinases, including Akt, ERK and MEK. Such modulation affects biological functions, for example, by inhibiting cell proliferation and/or inducing apoptosis. Also provided are pharmaceutical compositions and medicaments, comprising the compounds or salts of the invention, alone or in combination with other therapeutic agents or palliative agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.